In J20 mice, we also observed downregulation of Epac2, but not of Epac1, indicating that the loss of Epac2 is characteristic of early AD and unlikely to be a consequence of neurodegeneration. This evidence concerns the gene RAPGEF3 and Alzheimer disease.